NEIRG Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,747
Closed -$304K 16
2023
Q2
$304K Sell
4,747
-28
-0.6% -$1.88K 0.06% 118
2023
Q1
$331K Buy
4,775
+706
+17% +$49.8K 0.06% 121
2022
Q4
$293K Hold
4,069
0.06% 126
2022
Q3
$289K Sell
4,069
-386
-9% -$28K 0.06% 125
2022
Q2
$343K Buy
4,455
+904
+25% +$68.8K 0.07% 115
2022
Q1
$259K Buy
3,551
+100
+3% +$6.71K 0.05% 119
2021
Q4
$215K Buy
+3,451
New +$202K 0.04% 118

Other funds holding BMY

NEIRG Wealth Management's BMY Position: Q3 2023 in Review

NEIRG Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 4,747 shares — an estimated $304K sold.

NEIRG Wealth Management first reported a position in BMY in Q4 2021 and held it in 7 quarters. The position peaked at $343K in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • NEIRG Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • NEIRG Wealth Management sold 4,747 Bristol-Myers Squibb shares in Q3 2023, an estimated $304K.
  • NEIRG Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 7 quarters.
  • NEIRG Wealth Management's Bristol-Myers Squibb position peaked at $343K in Q2 2022.
  • 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on NEIRG Wealth Management's 13F filing for Q3 2023.